Catalyst Wire Dossier Catalyst Wire Dossier

Patanol (olopatadine hydrochloride) ophthalmic solution 0.1%

olopatadine hydrochloride · Alcon Research
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Patanol (olopatadine hydrochloride) ophthalmic solution 0.1%, covering 2015-05-12 to 2015-05-12. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients [Phase 4]

See pricing